This Week Subvariant Omicron BA.4-BA.5 Recorded 143 Cases, Mostly In DKI Jakarta, West Java And Banten

Screenshot of the Spokesman of the Indonesian Ministry of Health, Mohammad Syahril/ANTARA

JAKARTA - Spokesperson for the Ministry of Health, Mohammad Syahril, said that 143 cases of the Omicron BA.4 and BA.5 subvariants were detected in Indonesia in the past week. This number increased from the last report from the Ministry of Health as of June 14, 2022, which was 20 cases.

"The BA.4 cases are 21 cases and BA.5 cases are 122 cases. The most domicile of patients are in Jakarta, namely 98 cases, West Java 29 cases, Banten 13 cases, and Bali three cases," said Mohammad Syahril when delivering a press statement virtually which was followed by the Indonesian Ministry of Health's YouTube, Antara, Friday, June 24.

Syahril said the omicron subvariant affected 34 patients who had received booster doses, nine others who received the full dose, three patients who received the first dose, and one patient who received the fourth dose.

"The other five are pediatric patients who have not received the COVID-19 vaccine injection and the other 90 patients have no data updates," he said. If based on gender, said Syahril, 73 patients were male and 70 were female.

Syahril, who is also the President Director of RSPI Sulianti Saroso, said 38 patients were reported to be symptomatic, nine others were asymptomatic and the remaining 96 had no data updates.

"From the age classification, the most experienced productive age 30-39 years, which reached 34 patients, 29 other patients aged 20-29 years, while 20 elderly patients," he said.

The most dominant symptoms experienced by patients with the Omicron BA.5 subvariance were coughing 30 percent, fever 25 percent, runny nose 19 percent, sore throat 14 percent, the rest were nausea, shortness of breath and anosmia.

While the symptoms in BA.4 patients were dominated by cough 38 percent, fever 29 percent, sore throat 24 percent, colds and flu 9 percent.